The pharmaceutical company Pfizer and its German partner BioNTech are preparing for a trial in 2024 with the company Modern in it London High Court (UK) in the case of competing patent claims on COVID-19 vaccines.
The case came to the London High Court for the first time for a preliminary hearing this Thursday, before a trial that will take place in April 2024according to Reuters news agency reported. It should be remembered that Pfizer and BioNTech sued Moderna in September, with the aim of revoking two of the patents related to their vaccines. messenger RNA (mRNA).
Pfizer, BioNTech and Moderna are also litigating in Germany, the Netherlands and the United States
Moderna filed its own lawsuit that month over the vaccine. Comirnaty of Pfizer and BioNTech, in order to obtain damages for the alleged infringement of their patents. Pfizer, BioNTech and Moderna are also litigating in Germany, Netherlands y USA.
Moderna’s lawsuits in Germany and the United States, specifically, were filed on the same day in August, while Pfizer and BioNTech are in court. counterclaim processes in United States. In parallel, the three companies are involved in US patent disputes with other companies over vaccines.
Moderna filed its own lawsuit that month over Pfizer and BioNTech’s Comirnaty vaccine, seeking damages for alleged infringement of their patents.
CureVacwhich develops mRNA technology, is involved in patent lawsuits with Pfizer and BioNTech in Germany and the United States, as well as in London’s High Court, where a trial is expected to take place in July 2024.
